Skip to main content

Johnson & Johnson (JNJ)

Sector
Health Care
Industry
Pharmaceuticals
Last price
$280.41
As of

Kresmion compiles this page from JNJ's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

JOHNSON & JOHNSON (JNJ): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-10-21.

As of . Source: SEC EDGAR filings for JNJ. Method and limitations.

COMPANY DOSSIER

See the full JNJ dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for JNJ on one page. Preview it with sample data, then open it live with a free account.

Preview the JNJ dossier

Active events for JNJ

FREE, NO ACCOUNT

Every event on JNJ, as it fires

You are seeing 5 of 51 events recorded on JNJ since 2026-06-10.

The five above landed across 2 days. The other 46 were recorded on 15 other days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

JNJ positions held by the managers we follow (2026Q2)

What the managers we follow bought and sold in Q2 2026

Manager / securityMarket value% of reported value
CITADEL ADVISORS LLC FundCUSIP 478160104 · 2026Q2$381.2M0.22%
D. E. Shaw & Co., Inc. FundCUSIP 478160104 · 2026Q2$174.5M0.11%
Bridgewater Associates, LP FundCUSIP 478160104 · 2026Q2$169.9M0.70%
MILLENNIUM MANAGEMENT LLC FundCUSIP 478160104 · 2026Q2$150.9M0.10%
TWO SIGMA INVESTMENTS, LP FundCUSIP 478160104 · 2026Q2$8.9M0.01%
SOROS FUND MANAGEMENT LLC FundCUSIP 478160104 · 2026Q2$8.6M0.11%

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, JNJ

More data on JNJ

JNJ against its peers

JNJ's net margin of 28.5% ranks in the 90th percentile of 23 Pharmaceuticals sub-industry peers, fiscal periods ending between 2025-12-28 and 2025-12-31.

MetricJNJPeer medianPercentilen
Revenue FY94.2B USD5.2B USD9822
Gross margin67.9%74.3%2815
Operating marginn/a12.5%n/a17
Net margin28.5%8.9%9023
Return on equity32.9%15.4%7323
P / E25.4x20.8x6512
1 year44.7%29.1%6325

Peers (25): MRK, LLY, NVS, AZN, NVO, PFE, BMY, GSK, TEVA, ZTS, VTRS, JAZZ, CORT, AMRX, AXSM, AMLX, LQDA, OGN, TARS, BHC, XERS, HRMY, TRVI, SUPN, ANIP. Fiscal periods ending between 2025-12-28 and 2025-12-31. Every figure is one full fiscal year read from one annual filing (JNJ: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

Cite this data

Kresmion counts the managers it follows that reported a non-option position in JNJ on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on JNJ in the last 180 days.

Upstream: SEC EDGAR filings for JNJ

Kresmion, "JOHNSON & JOHNSON (JNJ) institutional holdings and SEC filings", data as of 2026-10-21, https://kresmion.com/research/JNJ. Upstream data: SEC EDGAR filings for JNJ.

Link to this data (HTML):

<a href="https://kresmion.com/research/JNJ">JOHNSON JOHNSON (JNJ) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow JNJ on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to JNJ for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the JNJ dossier
Share

The JNJ intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.